12 Health Care Stocks Moving In Friday's After-Market Session
Portfolio Pulse from Benzinga Insights
In Friday's after-market session, several health care stocks showed significant movement. Notably, Singular Genomics Systems, Vaccinex, and Celularity experienced upward movements, while Intelligent Bio Solutions, Perspective Therapeutics, and NanoString Technologies were among the losers. The changes in stock prices reflect varying market capitalizations, highlighting the dynamic nature of the health care sector in the stock market.

February 09, 2024 | 9:31 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Celularity shares increased by 7.52% to $0.46, with a market value of $99.5 million.
The upward trend in CELU's stock price suggests positive investor sentiment, which could lead to short-term price appreciation.
CONFIDENCE 80
IMPORTANCE 60
RELEVANCE 80
POSITIVE IMPACT
Singular Genomics Systems shares surged 17.9% to $0.66, with a market cap of $48.4 million.
The significant upward movement in OMIC's stock price could attract investor interest, potentially leading to short-term positive momentum.
CONFIDENCE 80
IMPORTANCE 70
RELEVANCE 90
POSITIVE IMPACT
Vaccinex stock increased by 11.61% to $0.77, with a market cap of $9.6 million.
VCNX's notable increase could indicate growing investor confidence, potentially leading to further short-term gains.
CONFIDENCE 80
IMPORTANCE 65
RELEVANCE 85
NEGATIVE IMPACT
Perspective Therapeutics stock fell 8.9% to $0.82, with a market cap of $405.5 million.
CATX's decrease could reflect concerns among investors, possibly leading to further short-term downward pressure on the stock.
CONFIDENCE 80
IMPORTANCE 65
RELEVANCE 85
NEGATIVE IMPACT
Intelligent Bio Solutions stock declined by 15.8% to $5.7, with a market cap of $4.1 million.
The sharp decline in INBS's stock price could indicate negative market sentiment, potentially leading to further short-term losses.
CONFIDENCE 80
IMPORTANCE 70
RELEVANCE 90
NEGATIVE IMPACT
NanoString Technologies stock decreased by 7.83% to $0.21, with a market cap of $10.2 million.
The decline in NSTG's stock price may signal negative investor sentiment, potentially leading to further short-term declines.
CONFIDENCE 80
IMPORTANCE 60
RELEVANCE 80